XOMA : Analysis & Opinions

  1. XOMA Reports Success in Insulin Trials (XOMA)

    September 16, 2016
    XOMA’s 358 trial success indicates its lead in offering the therapy for widespread insulin-related abnormalities.
  2. Every Biotech Catalyst Wedbush Is Watching In 2016

    January 2, 2016
    In a new report, Wedbush analyst Liana Moussatos breaks down potential 2016 catalysts for every emerging pharmaceuticals ...
Trading Center